FDA advisory panel says agency should redo BPA risk assessment

The U.S. Food and Drug Administration should redo its flawed risk assessment that found the chemical bisphenol A is harmless, an FDA advisory panel said on Friday. The advisory panel’s finding is an amen to an independent assessment of the FDA’s findings released last week.

The U.S. Food and Drug Administration should redo its flawed risk assessment that found the chemical bisphenol A is harmless, an FDA advisory panel said on Friday. The advisory panel’s finding is an amen to an independent assessment of the FDA’s findings released last week.

A message from

All donations DOUBLED!

Grist is the only award-winning newsroom focused on exploring equitable solutions to climate change. It’s vital reporting made entirely possible by loyal readers like you. At Grist, we don’t believe in paywalls. Instead, we rely on our readers to pitch in what they can so that we can continue bringing you our solution-based climate news.

Donate Now Not Now